BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies, (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergies, announced today its financial calendar for 2013*. Financial publications will be released after market close.
Full-year 2012 top-line Thursday, January 31st 2013
Full-year 2012 results Monday, March 4th 2013
First quarter 2013 top-line Monday, April 15th 2013
Half-year 2013 results Friday, July 26th 2013
First nine months 2013 top-line Tuesday, October 15th 2013
